Refine by
Human Leukocyte Antigen Equipment & Supplies
14 equipment items found
Manufactured by:Pharmigene, Inc. based inNeihu Dist, TAIWAN
The HLA-A*3101 allele is associated with Carbamazepine (CBZ)-induced hypersensitivity reactions in patients of Northern European and Japan ancestry. HLA-A*3101 is located on chromosome 6 and belongs to the family of human leukocyte antigens. Detection of this allele can be used to identify patients who may be at greater risk of CBZ-induced ...
Manufactured by:Pharmigene, Inc. based inNeihu Dist, TAIWAN
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of Human Leukocyte Antigen (HLA-B*1502) and Internal Control. Analysis is based on Ct values. A complete kit version has IVD approval from Department of Health, ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
A universal donor cell is a kind of cell that can be used for transplantation into anyone. In other words, it is a cell in which the induction of immune rejection*１ (Human Leukocyte Antigen（HLA*２）mismatch) has been suppressed, and which can be used for patients ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
Carbamazepine is an anticonvulsant commonly prescribed for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia, but can also cause severe cutaneous adverse reactions in patients who are positive for variant alleles HLA-A*31:01 or HLA-B*15:02. ViennaLab RealFast™ Assays discriminate between the presence or absence of these alleles and thus are a tool to prevent ...
Manufactured by:Pharmigene, Inc. based inNeihu Dist, TAIWAN
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5701 and Internal Control. Analysis is based on Ct ...
Manufactured by:Immucor based inNorcross, GEORGIA (US) (USA)
Platelet detection allows laboratories to determine compatibility between patient and donor prior to platelet transfusion. Platelet detection allows laboratories to determine compatibility between patient and donor prior to platelet transfusion. Our complete portfolio includes a variety of products for platelet antibody ...
Manufactured by:Pharmigene, Inc. based inNeihu Dist, TAIWAN
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*5801 and Internal Control. Analysis is based on Ct values. A complete kit version has IVD approval from Department of Health, ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
HLA-B*57:01 is a genetic risk factor for hypersensitivity reactions to abacavir, an antiretroviral drug used in HIV therapy. The HLA-B5701 RealFast™ Assay determines the presence or absence of HLA-B*57:01 alleles in ...
Manufactured by:Universal Cells Inc. based inSeattle, WASHINGTON (USA)
Realizing the potential of pluripotent stem cells requires that the therapeutic cells derived from PSCs be accepted by patients. PSC-derived cells that have not been engineered to avoid allogeneic rejection will be eliminated soon after transplantation unless they are HLA-matched to their recipients, delivered to immune privileged sites, or administered along with potentially dangerous ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Methyl 2-Octynoate is a ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
AllCells’ GMP Fresh Leukopak products are collected by apheresis from peripheral blood of healthy donors. Our Leukopaks contain a high concentration of lymphocyte populations, T Cells, B Cells, NK Cells, and monocytes. AllCells maintains on-site, FDA-registered donor centers for the collection of all products from IRB-consented healthy donors providing customers with a streamlined process ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our goal is to revolutionize cancer therapy on a global basis by developing TCR T-cell therapies (called SPEAR T-cells) with the potential to treat a wide range of cancer types and patients. Our TCR T-cell therapies have advantages over other immune therapies and cancer therapies. The video below provides more ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous vaccine models used inadequate ...
by:The Regeneration Center based inBangkok, THAILAND
Several clinical studies have clearly demonstrated the benefits of stem cells. Peer-reviewed medical journals today are intent on finding the richest source of stem cells in the human body. Researchers have found that umbilical cord blood is rich in stem cells, which eventually paved the way for researchers to move away from the controversial embryonic stem cells. As a result of these trials, it ...